117 related articles for article (PubMed ID: 8583839)
21. Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs.
Lee DW; Sung MW; Park SW; Seong WJ; Roh JL; Park B; Heo DS; Kim KH
Anticancer Res; 2002; 22(4):2089-96. PubMed ID: 12174888
[TBL] [Abstract][Full Text] [Related]
22. [The role and clinical significance of 12-LOX passway in arachidonic acid metabolism induced by phospholipase Cgamma-2 in laryngeal squamous cell carcinoma].
Wang J; Li X; Xu O; Shan C
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Dec; 27(24):1355-9. PubMed ID: 24669684
[TBL] [Abstract][Full Text] [Related]
23. Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer.
Lin DT; Subbaramaiah K; Shah JP; Dannenberg AJ; Boyle JO
Head Neck; 2002 Aug; 24(8):792-9. PubMed ID: 12203806
[TBL] [Abstract][Full Text] [Related]
24. The effect of inhibitors of arachidonic acid metabolism on proliferation and death of tumor cells.
Korystov YuN ; Shaposhnikova VV; Levitman MKh; Kudryavtsev AA; Kublik LN; Narimanov AA; Orlova OE
FEBS Lett; 1998 Jul; 431(2):224-6. PubMed ID: 9708907
[TBL] [Abstract][Full Text] [Related]
25. Anticancer activity of Scutellaria baicalensis and its potential mechanism.
Ye F; Xui L; Yi J; Zhang W; Zhang DY
J Altern Complement Med; 2002 Oct; 8(5):567-72. PubMed ID: 12470437
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of docetaxel-induced cytotoxicity by blocking epidermal growth factor receptor and cyclooxygenase-2 pathways in squamous cell carcinoma of the head and neck.
Choe MS; Chen Z; Klass CM; Zhang X; Shin DM
Clin Cancer Res; 2007 May; 13(10):3015-23. PubMed ID: 17505004
[TBL] [Abstract][Full Text] [Related]
27. Expression levels of Akt in nimesulide-treated squamous carcinoma cell lines of the head and neck.
Vormittag L; Lamm W; Erovic BM; Czembirek C; Kornek G; Thurnher D
Oncol Rep; 2005 Feb; 13(2):207-10. PubMed ID: 15643499
[TBL] [Abstract][Full Text] [Related]
28. Expression of retinoic acid receptor gamma correlates with retinoic acid sensitivity and metabolism in head and neck squamous cell carcinoma cell lines.
Klaassen I; Brakenhoff RH; Smeets SJ; Snow GB; Braakhuis BJ
Int J Cancer; 2001 Jun; 92(5):661-5. PubMed ID: 11340568
[TBL] [Abstract][Full Text] [Related]
29. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL
Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of U937 eicosanoid and DNA synthesis by 5,8,11,14-eicosatetraynoic acid, an inhibitor of arachidonic acid metabolism and its partial reversal by leukotriene C4.
Ondrey F; Harris JE; Anderson KM
Cancer Res; 1989 Mar; 49(5):1138-42. PubMed ID: 2492901
[TBL] [Abstract][Full Text] [Related]
31. Targeting serum glucocorticoid-regulated kinase-1 in squamous cell carcinoma of the head and neck: a novel modality of local control.
Berdel HO; Yin H; Liu JY; Grochowska K; Middleton C; Yanasak N; Abdelsayed R; Berdel WE; Mozaffari M; Yu JC; Baban B
PLoS One; 2014; 9(12):e113795. PubMed ID: 25485633
[TBL] [Abstract][Full Text] [Related]
32. IL-6 Inhibition With MEDI5117 Decreases The Fraction of Head and Neck Cancer Stem Cells and Prevents Tumor Recurrence.
Finkel KA; Warner KA; Kerk S; Bradford CR; McLean SA; Prince ME; Zhong H; Hurt EM; Hollingsworth RE; Wicha MS; Tice DA; Nör JE
Neoplasia; 2016 May; 18(5):273-281. PubMed ID: 27237319
[TBL] [Abstract][Full Text] [Related]
33. Action of low calcemic 1alpha,25-dihydroxyvitamin D3 analogue EB1089 in head and neck squamous cell carcinoma.
Prudencio J; Akutsu N; Benlimame N; Wang T; Bastien Y; Lin R; Black MJ; Alaoui-Jamali MA; White JH
J Natl Cancer Inst; 2001 May; 93(10):745-53. PubMed ID: 11353784
[TBL] [Abstract][Full Text] [Related]
34. Prostaglandins in squamous cell carcinoma of the head and neck: a preliminary study.
Jung TT; Berlinger NT; Juhn SK
Laryngoscope; 1985 Mar; 95(3):307-12. PubMed ID: 3919231
[TBL] [Abstract][Full Text] [Related]
35. Regression of head and neck carcinoma with a prostaglandin-synthesis inhibitor.
Panje WR
Arch Otolaryngol; 1981 Nov; 107(11):658-63. PubMed ID: 7295159
[TBL] [Abstract][Full Text] [Related]
36. Importance of pharmacodynamics in the in vitro antiproliferative activity of the antifolates methotrexate and 10-ethyl-10-deazaaminopterin against human head and neck squamous cell carcinoma.
Braakhuis BJ; Jansen G; Noordhuis P; Kegel A; Peters GJ
Biochem Pharmacol; 1993 Dec; 46(12):2155-61. PubMed ID: 7506025
[TBL] [Abstract][Full Text] [Related]
37. Effect of inhibitors of arachidonic acid metabolism on corneal reepithelialization in the rat.
Gupta AG; Hirakata A; Proia AD
Exp Eye Res; 1993 Jun; 56(6):701-8. PubMed ID: 8595812
[TBL] [Abstract][Full Text] [Related]
38. Role of arachidonic acid metabolism in thymocyte apoptosis after irradiation.
Korystov YN; Dobrovinskaya OR; Shaposhnikova VV; Eidus LKh
FEBS Lett; 1996 Jun; 388(2-3):238-41. PubMed ID: 8690095
[TBL] [Abstract][Full Text] [Related]
39. Regulation of T-lymphopoiesis by arachidonic acid metabolites.
Miller AM; Elfenbein GJ; Barth KC
Exp Hematol; 1989 Feb; 17(2):198-202. PubMed ID: 2536330
[TBL] [Abstract][Full Text] [Related]
40. Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase.
Ghosh J; Myers CE
Biochem Biophys Res Commun; 1997 Jun; 235(2):418-23. PubMed ID: 9199209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
